ASH 41st (2000)

Title Content type
INDUCTION OF COMPLETE REMISSION OF ADVANCED STAGE MYCOSIS FUNGOIDES BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT. (click for details)
BIPHENOTYPIC LEUKEMIA WITH COEXPRESSION OF MEGAKARYOBLASTIC MARKERS IN PEDIATRIC LEUKEMIAS. (click for details)
EVALUATION OF EARLY TOXICITY OF RABBIT ANTI THYMOCYTE GLOBULIN (THYMOGLOBULINER, ATG) FOR PREPARATION OF ALLOGENEIC STEM CELL TRANSPLANTATION (SCT). (click for details)
AMIFOSTINE (AMI) BEFORE FTBI, FOLLOWED BY VP-16, CYTOXAN (CY) AND AUTOLOGOUS PBSCT FOR PATIENTS WITH RELAPSED NHL, HD AND ACUTE LEUKEMIA: TOXICITY ANALYSIS. (click for details)
PCR monitoring of sequential BAL samples to identify patients at high risk to develop invasive pulmonary Aspergillosis post-BMT (click for details)
BUSULFAN/CYCLOPHOSPHAMIDE/FLUDARABINE (BCF) CONDITIONING PRIOR TO VOLUNTEER UNRELATED DONOR (VUD) BMT FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A POTENTIAL ALTERNATIVE TO TBI CONTAINING PREPARATIVE REGIMENS. (click for details)
IL-1(3 COSTIMULATES CYTOKINE PRODUCTION BY CD56bright HUMAN NATURAL KILLER (NK) CELLS. (click for details)
OMISSION OF GvHD PROPHYLAXIS IS FEASIBLE AND LEADS TO HIGH RESPONSE RATES IN REFRACTORY HEMATOLOGIC MALIGNANCIES. (click for details)
SUCCESSFUL NON-SURGICAL TREATMENT OF DISSEMINATED POLYMICROBIAL FUNGAL INFECTION OF LUNGS AND BRAIN IN A PATIENT WITH PANCYTOPENIA AND GVHD. (click for details)
IN VIVO PURGING WITH HIGH DOSE CYTARABINE FOLLOWED BY HIGH-DOSE THERAPY AND REINFUSION OF UNPURGED PERIPHERAL STEM CELLS FOR MYELODYSPLASIA OR SECONDARY ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION. (click for details)

Pages

Subscribe to ASH 41st (2000)